← Leaderboards
Raymond J Peterson
Brigham And Women'S Hospital
$6,571,498
Attributed
$13,142,995
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.6M · FY2012–16$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$25,766,269 · 7
By mechanism
U54$25,766,269 · 7
Top collaborators
- Calum A. Macrae16 shared
- Randall T Peterson11 shared
- Gerry R Boss5 shared
- Robert E Gerszten5 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Jessica R. Allegretti$3,079,283
Others in their field
Top investigators on “Cyanides”
- Gerry R Boss · University Of California San Diego$17,809,474
- Calum A. Macrae · Massachusetts General Hospital$10,627,087
- Steven E Patterson · University Of Minnesota$8,871,669
- Randall T Peterson · Massachusetts General Hospital$4,974,668
- Rakesh Pravinchandra Patel · Medical College Of Wisconsin$4,879,176
- Matthew Brenner · University Of California Irvine$4,840,532
Research focus
CyanidesToxic EffectZebrafishPathway InteractionsExposure ToMetabolomicsOryctolagus CuniculusIn VivoEfficacy TestingAntidotesPharmaceutical ChemistryStructure-Activity RelationshipBaseResponseDesignDoseMethodologyPre-ClinicalPharmaceutical PreparationsMetabolicIndustrial AccidentsSeriesBloodEnsure
Grant awards (37)
A Discovery and Development Pipeline for Cyanide Countermeasures$2,398,236
U54 · FY2016 · NS
Metabolomic phenotyping ("Metabolomics")$645,687
U54 · FY2016 · NS
Validating promising drug candidates in mammalian models of CN poisoning$482,546
U54 · FY2016 · NS
Administrative core for center management and operations$382,073
U54 · FY2016 · NS
Optimizing novel cyanide countermeasures$376,561
U54 · FY2016 · NS
Training and Education Core$284,148
U54 · FY2016 · NS
High throughput in vivo discovery of cyanide antidotes$227,221
U54 · FY2016 · NS
A Discovery and Development Pipeline for Cyanide Countermeasures$150,000
U54 · FY2016 · NS
Optimizing novel cyanide countermeasures$150,000
U54 · FY2016 · NS
A Discovery and Development Pipeline for Cyanide Countermeasures$2,443,895
U54 · FY2015 · NS
Metabolomic phenotyping ("Metabolomics")$641,596
U54 · FY2015 · NS
Validating promising drug candidates in mammalian models of CN poisoning$482,823
U54 · FY2015 · NS
Administrative core for center management and operations$379,653
U54 · FY2015 · NS
Optimizing novel cyanide countermeasures$376,262
U54 · FY2015 · NS
Training and Education Core$336,273
U54 · FY2015 · NS
High throughput in vivo discovery of cyanide antidotes$227,288
U54 · FY2015 · NS
A Discovery and Development Pipeline for Cyanide Countermeasures$2,396,827
U54 · FY2014 · NS
Metabolomic phenotyping ("Metabolomics")$645,606
U54 · FY2014 · NS
Validating promising drug candidates in mammalian models of CN poisoning$482,551
U54 · FY2014 · NS
Administrative core for center management and operations$382,025
U54 · FY2014 · NS
Optimizing novel cyanide countermeasures$375,311
U54 · FY2014 · NS
Training and Education Core$284,112
U54 · FY2014 · NS
High throughput in vivo discovery of cyanide antidotes$227,222
U54 · FY2014 · NS
A Discovery and Development Pipeline for Cyanide Countermeasures$2,526,499
U54 · FY2013 · NS
Metabolomic phenotyping ("Metabolomics")$766,445
U54 · FY2013 · NS
Validating promising drug candidates in mammalian models of CN poisoning$569,733
U54 · FY2013 · NS
Optimizing novel cyanide countermeasures$562,059
U54 · FY2013 · NS
Administrative core for center management and operations$454,320
U54 · FY2013 · NS
Training and Education Core$402,409
U54 · FY2013 · NS
High throughput in vivo discovery of cyanide antidotes$291,254
U54 · FY2013 · NS
A Discovery and Development Pipeline for Cyanide Countermeasures$2,707,817
U54 · FY2012 · NS
Metabolomic phenotyping ("Metabolomics")$819,839
U54 · FY2012 · NS
Administrative core for center management and operations$623,051
U54 · FY2012 · NS
Validating promising drug candidates in mammalian models of CN poisoning$423,734
U54 · FY2012 · NS
Training and Education Core$360,797
U54 · FY2012 · NS
Optimizing novel cyanide countermeasures$315,819
U54 · FY2012 · NS
High throughput in vivo discovery of cyanide antidotes$164,577
U54 · FY2012 · NS